Method for fast and efficient separation and purification of tumor cells from malignant pleural effusion and ascites
A technology for the separation and purification of tumor cells, which is applied in the field of fast and efficient separation and purification of tumor cells from malignant pleural effusion, which can solve the problems of separation and purification steps, the inability to conduct further research, and the small amount of cell collection, so as to achieve small cell damage , Tumor cells are in good condition, and the effect is reproducible
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Example Embodiment
[0030] Example 1
[0031] 1. Main experimental materials
[0032] (1) Source of pleural fluid: pleural effusion of patients with lung adenocarcinoma.
[0033] (2) PBS solution: potassium dihydrogen phosphate (KH 2 PO 4 ): 0.27g, disodium hydrogen phosphate (Na 2 HPO 4 ): 1.42g, sodium chloride (NaCl): 8g, potassium chloride (KCl) 0.2g, add about 800mL of deionized water to fully stir to dissolve, then add concentrated hydrochloric acid to adjust the pH to 7.2-7.4, and finally dilute to 1L. Prepared 24 hours before the experiment, sterilized at high temperature and autoclaved, and sealed at room temperature.
[0034] (3) Calf serum: Hangzhou Sijiqing Company.
[0035] (4) 50ml centrifuge tube: American BD company.
[0036] (5) Sterile glass Pasteur pipette: American Fasher company
[0037] (6) Centrifuge: Eppendrof, Germany
[0038] 2. Operation steps
[0039] (1) Aseptically extract 500ml of pleural effusion from lung cancer patients, take 200ml from it, put them into 4 50ml centrifuge ...
Example Embodiment
[0042] Example 2
[0043] The difference from Example 1 is:
[0044] 2. Operation steps
[0045] (1) Aseptically extract 500ml of pleural effusion from lung cancer patients, take 200ml from it, put them into 4 50ml centrifuge tubes, and centrifuge at 1500r / min for 5 minutes at room temperature to obtain cell pellet.
[0046] (2) Collect and mix the cell pellet with 20ml PBS liquid to obtain a tumor cell suspension. Take a sterile 50ml centrifuge tube and add 30ml calf serum. The specific viscosity of the serum (relative to distilled water) is 1.8. Use a Pasteur pipette to gently add the mixed tumor cell suspension to the serum along the tube wall to divide it into two layers, with the tumor cell suspension layer on top and the serum layer on the bottom, and the height is not less than 4cm.
[0047] (3) Leave the centrifuge tube added with the tumor cell suspension layer for 5 minutes. Use a Pasteur pipette to suck 5ml of serum from the bottom of the centrifuge tube. Take care not to...
Example Embodiment
[0048] Example 3
[0049] The difference from Example 1 is:
[0050] 2. Operation steps
[0051] (1) Aseptically extract 500ml of pleural effusion from lung cancer patients, take 200ml from it, put them into 4 50ml centrifuge tubes, and centrifuge at 1500r / min for 5 minutes at room temperature to obtain cell pellet.
[0052] (2) Collect and mix the cell pellet with 20ml PBS liquid to obtain a tumor cell suspension. Take a sterile 50ml centrifuge tube and add 20ml calf serum. The specific viscosity of the serum (relative to distilled water) is 1.6. Use a Pasteur pipette to gently add the mixed tumor cell suspension to the serum along the tube wall to divide it into two layers, with the tumor cell suspension layer on top and the serum layer on the bottom, and the height is not less than 4cm.
[0053] (3) Leave the centrifuge tube with the tumor cell suspension layer to stand for 6 minutes, and use a Pasteur pipette to suck 5ml of serum from the bottom of the centrifuge tube. Take care...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap